4,4,5,5-TETRAMETHYL-2-(4-((4-(TRIFLUOROMETHYL)BENZYL)OXY)PHENYL)-1,3,2-DIOXABOROLANE, 95%, 5g

2-(2-Chlorophenyl)-2-fluoroacetic acid, 95%, 10g

METHYL 5-[(1S)-1-AMINO-2-HYDROXYETHYL]-2-CHLOROBENZOATE HCL, 95.0%, 250mg

4-Trifluoroacetyl-3-methyl-1-phenyl-5-pyrazolone, 96.0%, 5g

4-(4-tert-Butylphenyl)-4-oxobutyric acid, 95.0%, 10g

4-(Methylsulfonyl) phenylacetonitrile, 95.0%, 25g

4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-1-(4-methylbenzyl)piperidine-4-carboxylic acid, 98%, 100mg

6-BROMO-3-CYCLOPROPYL-1H-INDAZOLE, 95%, 250mg

(Hydroxymethyl)triphenylphosphonium chloride, 95.0%, 10g

1-BOC-3-O-TOLYLPIPERAZINE, 95.0%, 1g

GC capillary column ROTI®Cap-1, 10 m, 0.53 mm, 1.00 µm, 1 Piece(s)

(1-cyclopentyl-1H-imidazol-5-yl)methanol, 95.0%, 10g

2-(2-METHYLPROPYL)-3-PYRIDINEMETHANOL, 95.0%, 100mg